Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05899387 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Seroma of the Mammary Gland

Study acronym: SerMa
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Phase: Not specified to Not applicable
    • Primary completion date: Jul 1, 2024 to Jul 1, 2027
    • Interventions: Blood sampling (Procedure), Seroma punction (Procedure), Swap collection (Procedure) to Blood sampling (Procedure), Seroma punction (Procedure), Sonographic correlation Seroma (Diagnostic Test), Swap collection (Procedure)
    v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 1, 2024 to Apr 1, 2024
    • Study sites: 0 to 1
    v3
  3. Primary completion date: Nov 1, 2023 to Jul 1, 2024
    • Start date: Jul 1, 2023 to Jan 1, 2024
    • Study completion date: Nov 1, 2026 to Jul 1, 2027
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study is designed as international, prospective, minimal interventional study in cooperation with EUBREAST e.V. (European Breast Cancer Research Association of Surgical Trialists). Furthermore, it is planned to initiate a registry for postoperative breast seromas.
Trial Details
NCT Number NCT05899387
Lead Sponsor University Hospital Augsburg
Conditions
(from sponsor)		 Seroma, Breast Cancer, Mastectomy, Breast Implant; Complications
Related terms Breast Neoplasms, Seroma
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov